US › Healthcare

Cosmos Health Inc. (COSM)

US · Healthcare · Medical Distribution

$0.30+8.14%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$19.0M

Revenue YoY

+28.8%

Net profit

$-6.1M

EPS

$-0.03

EPS estimate

$0.01

Net margin

-32.1%

EPS came in at -0.03 against a street estimate of 0.01 — a miss of 400.0%.

Key statistics

Market cap

$25.5M

Forward P/E

3.6

P/B

1.23

Book value

$0.26

EPS (TTM)

$-0.67

52-week high

$1.32

52-week low

$0.16

50-day MA

$0.23

200-day MA

$0.34

Beta

4.17

Analyst view

Analysts rate Cosmos Health Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $4.50.

Shareholding

Insiders

21.68%

Institutions

3.67%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	0.39%
Geode Capital Management, LLC	0.32%
BlackRock Inc	0.27%
Vanguard Capital Management, LLC	0.14%
Vanguard Fiduciary Trust Co	0.10%
HRT FINANCIAL LLC	0.07%
State Street Corp	0.04%
XTX Topco Ltd	0.04%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cosmos Health Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.